Trastuzumab-induced thrombocytopenia after eight cycles of trastuzumab treatment

Trastuzumab, a humanized monoclonal antibody derived from recombinant DNA, is used in patients with breast cancer with HER2 gene amplification. The survival benefit from trastuzumab has been well established in patients with early and metastatic breast cancer who had over expression of HER2. We repo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Qiong, Dong, Jie, Jiang, Xiaodong, Pan, Yueyin, Han, Xinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711970/
https://www.ncbi.nlm.nih.gov/pubmed/33336023
http://dx.doi.org/10.1515/med-2020-0201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711970/
https://www.ncbi.nlm.nih.gov/pubmed/33336023
http://dx.doi.org/10.1515/med-2020-0201

Ejemplares similares